Advertisement
Advertisement
TXG
10x Genomics, Inc. Class A Common Stock
22.47
USDSponsored
+0.42
+1.92%
Apr 02, 10:45 UTC -4
Open
TXG Earnings Reports
Positive Surprise Ratio
TXG beat 14 of 26 last estimates.
54%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$147.78M
/-$0.29
Implied change from Q4 25 (Revenue/ EPS)
-10.99%
/+123.08%
Implied change from Q1 25 (Revenue/ EPS)
-4.58%
/-19.44%
10x Genomics, Inc. Class A Common Stock earnings per share and revenue
On Feb 12, 2026, TXG reported earnings of -0.13 USD per share (EPS) for Q4 25, beating the estimate of -0.21 USD, resulting in a 39.42% surprise. Revenue reached 166.03 million, compared to an expected 160.87 million, with a 3.21% difference. The market reacted with a +3.64% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 16 analysts forecast an EPS of -0.29 USD, with revenue projected to reach 147.78 million USD, implying an increase of 123.08% EPS, and decrease of -10.99% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Phreesia, Inc.
Report Date
Mar 30, 2026 For Q4 26
Estimate
$0.07
Actual
$0.12
Surprise
+62.82%
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
Insight Molecular Diagnostics Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.24
Actual
-$0.27
Surprise
-11.57%
Neuraxis, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.21
Actual
-$0.17
Surprise
+22.48%
FAQ
What were 10x Genomics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, 10x Genomics, Inc. Class A Common Stock reported EPS of -$0.13, beating estimates by 39.42%, and revenue of $166.03M, 3.21% above expectations.
How did the market react to 10x Genomics, Inc. Class A Common Stock's Q4 2025 earnings?
The stock price moved up 3.64%, changed from $19.80 before the earnings release to $20.52 the day after.
When is 10x Genomics, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for 10x Genomics, Inc. Class A Common Stock's next earnings report?
Based on 16
analysts, 10x Genomics, Inc. Class A Common Stock is expected to report EPS of -$0.29 and revenue of $147.78M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement